Cargando…

Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts

Background: Over the past 15 years, comparative assessments of psychoactive substance harms to both users and others have been compiled by addiction experts. None of these rankings however have included synthetic cannabinoids or non-opioid prescription analgesics (NOAs, e.g., gabapentinoids) despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonnet, Udo, Specka, Michael, Soyka, Michael, Alberti, Thomas, Bender, Stefan, Grigoleit, Torsten, Hermle, Leopold, Hilger, Jörg, Hillemacher, Thomas, Kuhlmann, Thomas, Kuhn, Jens, Luckhaus, Christian, Lüdecke, Christel, Reimer, Jens, Schneider, Udo, Schroeder, Welf, Stuppe, Markus, Wiesbeck, Gerhard A., Wodarz, Norbert, McAnally, Heath, Scherbaum, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649209/
https://www.ncbi.nlm.nih.gov/pubmed/33192740
http://dx.doi.org/10.3389/fpsyt.2020.592199
_version_ 1783607275415404544
author Bonnet, Udo
Specka, Michael
Soyka, Michael
Alberti, Thomas
Bender, Stefan
Grigoleit, Torsten
Hermle, Leopold
Hilger, Jörg
Hillemacher, Thomas
Kuhlmann, Thomas
Kuhn, Jens
Luckhaus, Christian
Lüdecke, Christel
Reimer, Jens
Schneider, Udo
Schroeder, Welf
Stuppe, Markus
Wiesbeck, Gerhard A.
Wodarz, Norbert
McAnally, Heath
Scherbaum, Norbert
author_facet Bonnet, Udo
Specka, Michael
Soyka, Michael
Alberti, Thomas
Bender, Stefan
Grigoleit, Torsten
Hermle, Leopold
Hilger, Jörg
Hillemacher, Thomas
Kuhlmann, Thomas
Kuhn, Jens
Luckhaus, Christian
Lüdecke, Christel
Reimer, Jens
Schneider, Udo
Schroeder, Welf
Stuppe, Markus
Wiesbeck, Gerhard A.
Wodarz, Norbert
McAnally, Heath
Scherbaum, Norbert
author_sort Bonnet, Udo
collection PubMed
description Background: Over the past 15 years, comparative assessments of psychoactive substance harms to both users and others have been compiled by addiction experts. None of these rankings however have included synthetic cannabinoids or non-opioid prescription analgesics (NOAs, e.g., gabapentinoids) despite evidence of increasing recreational use. We present here an updated assessment by German addiction medicine experts, considering changing Western consumption trends–including those of NOAs. Methods: In an initial survey, 101 German addiction medicine physicians evaluated both physical and psychosocial harms (in 5 dimensions) of 33 psychoactive substances including opioids and NOAs, to both users and others. In a second survey, 36 addiction medicine physicians estimated the relative weight of each health and social harm dimension to determine the overall harm rank of an individual substance. We compared our ranking with the most recent European assessment from 2014. Results: Illicit drugs such as methamphetamine, heroin, cocaine and also alcohol were judged particularly harmful, and new psychoactive drugs (cathinones, synthetic cannabinoids) were ranked among the most harmful substances. Cannabis was ranked in the midrange, on par with benzodiazepines and ketamine—somewhat more favorable compared to the last European survey. Prescribed drugs including opioids (in contrast to the USA, Canada, and Australia) were judged less harmful. NOAs were at the bottom end of the ranking. Conclusion: In Germany, alcohol and illicit drugs (including new psychoactive substances) continue to rank among the most harmful addictive substances in contrast to prescribed agents including opioid analgesics and NOAs. Current laws are incongruent with these harm rankings. This study is the first of its kind to include comparative harm rankings of several novel abused substances, both licit/prescribed and illicit.
format Online
Article
Text
id pubmed-7649209
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76492092020-11-13 Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts Bonnet, Udo Specka, Michael Soyka, Michael Alberti, Thomas Bender, Stefan Grigoleit, Torsten Hermle, Leopold Hilger, Jörg Hillemacher, Thomas Kuhlmann, Thomas Kuhn, Jens Luckhaus, Christian Lüdecke, Christel Reimer, Jens Schneider, Udo Schroeder, Welf Stuppe, Markus Wiesbeck, Gerhard A. Wodarz, Norbert McAnally, Heath Scherbaum, Norbert Front Psychiatry Psychiatry Background: Over the past 15 years, comparative assessments of psychoactive substance harms to both users and others have been compiled by addiction experts. None of these rankings however have included synthetic cannabinoids or non-opioid prescription analgesics (NOAs, e.g., gabapentinoids) despite evidence of increasing recreational use. We present here an updated assessment by German addiction medicine experts, considering changing Western consumption trends–including those of NOAs. Methods: In an initial survey, 101 German addiction medicine physicians evaluated both physical and psychosocial harms (in 5 dimensions) of 33 psychoactive substances including opioids and NOAs, to both users and others. In a second survey, 36 addiction medicine physicians estimated the relative weight of each health and social harm dimension to determine the overall harm rank of an individual substance. We compared our ranking with the most recent European assessment from 2014. Results: Illicit drugs such as methamphetamine, heroin, cocaine and also alcohol were judged particularly harmful, and new psychoactive drugs (cathinones, synthetic cannabinoids) were ranked among the most harmful substances. Cannabis was ranked in the midrange, on par with benzodiazepines and ketamine—somewhat more favorable compared to the last European survey. Prescribed drugs including opioids (in contrast to the USA, Canada, and Australia) were judged less harmful. NOAs were at the bottom end of the ranking. Conclusion: In Germany, alcohol and illicit drugs (including new psychoactive substances) continue to rank among the most harmful addictive substances in contrast to prescribed agents including opioid analgesics and NOAs. Current laws are incongruent with these harm rankings. This study is the first of its kind to include comparative harm rankings of several novel abused substances, both licit/prescribed and illicit. Frontiers Media S.A. 2020-10-26 /pmc/articles/PMC7649209/ /pubmed/33192740 http://dx.doi.org/10.3389/fpsyt.2020.592199 Text en Copyright © 2020 Bonnet, Specka, Soyka, Alberti, Bender, Grigoleit, Hermle, Hilger, Hillemacher, Kuhlmann, Kuhn, Luckhaus, Lüdecke, Reimer, Schneider, Schroeder, Stuppe, Wiesbeck, Wodarz, McAnally and Scherbaum. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Bonnet, Udo
Specka, Michael
Soyka, Michael
Alberti, Thomas
Bender, Stefan
Grigoleit, Torsten
Hermle, Leopold
Hilger, Jörg
Hillemacher, Thomas
Kuhlmann, Thomas
Kuhn, Jens
Luckhaus, Christian
Lüdecke, Christel
Reimer, Jens
Schneider, Udo
Schroeder, Welf
Stuppe, Markus
Wiesbeck, Gerhard A.
Wodarz, Norbert
McAnally, Heath
Scherbaum, Norbert
Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
title Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
title_full Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
title_fullStr Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
title_full_unstemmed Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
title_short Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
title_sort ranking the harm of psychoactive drugs including prescription analgesics to users and others–a perspective of german addiction medicine experts
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649209/
https://www.ncbi.nlm.nih.gov/pubmed/33192740
http://dx.doi.org/10.3389/fpsyt.2020.592199
work_keys_str_mv AT bonnetudo rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT speckamichael rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT soykamichael rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT albertithomas rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT benderstefan rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT grigoleittorsten rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT hermleleopold rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT hilgerjorg rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT hillemacherthomas rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT kuhlmannthomas rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT kuhnjens rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT luckhauschristian rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT ludeckechristel rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT reimerjens rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT schneiderudo rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT schroederwelf rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT stuppemarkus rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT wiesbeckgerharda rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT wodarznorbert rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT mcanallyheath rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts
AT scherbaumnorbert rankingtheharmofpsychoactivedrugsincludingprescriptionanalgesicstousersandothersaperspectiveofgermanaddictionmedicineexperts